Patents for C12R 1 - Micro-organisms (92,025) |
---|
11/23/1995 | WO1995031538A1 Human dna topoisomerase i-alpha |
11/23/1995 | WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE |
11/23/1995 | WO1995031535A1 Ice and ice-like compositions and methods of making same |
11/23/1995 | WO1995031534A1 AN ENZYME WITH β-(1-6)-ENDOGLUCANASE ACTIVITY |
11/23/1995 | WO1995031483A1 Improvements in or relating to peptide delivery |
11/23/1995 | WO1995031476A1 Recombinant papilloma virus l1 |
11/23/1995 | WO1995031473A1 Collagen from cell cultures |
11/23/1995 | WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance |
11/23/1995 | WO1995031468A1 Macrophage migration inhibitory factor-3 |
11/23/1995 | WO1995031467A1 Monocyte chemotactic protein-4 |
11/23/1995 | WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
11/23/1995 | WO1995031206A1 P75 tnf receptor promoters |
11/23/1995 | WO1995029236A3 Lymphocyte activation antigens and antibodies thereto |
11/23/1995 | WO1995028957A3 Methods for inducing t cell tolerance to a tissue or organ graft |
11/23/1995 | WO1995026981A3 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
11/23/1995 | CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance |
11/23/1995 | CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
11/23/1995 | CA2190289A1 Dna construct for effecting homologous recombination and uses thereof |
11/23/1995 | CA2190264A1 Trimerising polypeptides, their manufacture and use |
11/23/1995 | CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme |
11/23/1995 | CA2190101A1 Improvements in or relating to peptide delivery |
11/23/1995 | CA2190090A1 Materials and methods for the detection of mycobacteria |
11/23/1995 | CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
11/23/1995 | CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
11/23/1995 | CA2189421A1 Collagen from cell cultures |
11/23/1995 | CA2188562A1 Method of introducing pathogen resistance in plants |
11/23/1995 | CA2188421A1 Alphavirus expression vector |
11/23/1995 | CA2188157A1 Nucleic acid sequences controlling lung cell-specific gene expression |
11/22/1995 | EP0683265A1 Pitch degradation with white rot fungus |
11/22/1995 | EP0683238A2 A process for the cloning of DNA |
11/22/1995 | EP0683235A1 A process for the preparation of enantiomeric 2-alkanoic acids |
11/22/1995 | EP0683233A2 Process for producing recombinant human serum albumin |
11/22/1995 | EP0683230A1 Vitreoscilla haemoglobin promoter/regulator controlled by the level of oxygen |
11/22/1995 | EP0683228A2 Novel expression system |
11/22/1995 | EP0683227A1 Human retinoic acid receptor and genes encoding for it |
11/22/1995 | EP0683145A1 A method for racemizing nitriles |
11/22/1995 | EP0682714A1 Novel neutrophil inhibitors |
11/22/1995 | EP0682710A1 Immobilized proteins with specific binding capacities and their use in processes and products |
11/22/1995 | EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
11/22/1995 | EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
11/22/1995 | EP0682702A1 Expression of protective antigens |
11/22/1995 | EP0682699A1 FUNCTIONAL DOMAINS IN $i(FLAVOBACTERIUM OKEANOKOITES) (FOKI) RESTRICTION ENDONUCLEASE |
11/22/1995 | EP0682529A1 Antibody for the treatment of insulin dependent diabetes |
11/22/1995 | EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
11/22/1995 | EP0571475B1 Sg(beta)-1,4-GALACTANASE AND A DNA SEQUENCE |
11/22/1995 | EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna |
11/22/1995 | CN1112356A Novel attenuated pseudomonas aeruginosa strains |
11/21/1995 | US5468849 Rebeccamycin analogs by tryptophan analogs feeding |
11/21/1995 | US5468846 Monoclonal antibodies and method for the determination of human G-CSF |
11/21/1995 | US5468773 Treating postmenopausal osteoporosis; side effect reduction |
11/21/1995 | US5468637 S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones |
11/21/1995 | US5468636 Aphidicides |
11/21/1995 | US5468635 In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme |
11/21/1995 | US5468631 Genetic engineering |
11/21/1995 | US5468625 α-L-Rhamnosidase for obtaining rhamnose, a process for its preparation and its use |
11/21/1995 | US5468621 Method of quantitative assay for 1,5-anhydroglucitol |
11/21/1995 | US5468615 Adding a compound to eukaryotic cell transformed with vector capable of expressing human dopamine receptor, assaying affinity of compound for receptor |
11/21/1995 | US5468609 Production of interferon |
11/21/1995 | US5468608 Production of interferon |
11/21/1995 | US5468607 Production of interferon |
11/21/1995 | US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD |
11/21/1995 | US5468416 Protease derived from Verticillium |
11/21/1995 | CA2149807A1 Pitch degradation with white rot fungus |
11/21/1995 | CA2149345A1 Epitopic regions of pneumococcal surface protein a |
11/21/1995 | CA2037634C Esterase and process for preparing the same |
11/21/1995 | CA1337597C Phosphinotricin-resistance gene, and its use |
11/21/1995 | CA1337596C Varicella-zoster virus as a live recombinant vaccine |
11/19/1995 | CA2149579A1 Process for producing recombinant human serum albumin |
11/18/1995 | CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica |
11/16/1995 | WO1995030763A2 Retroviral vectors having a reduced recombination rate |
11/16/1995 | WO1995030758A1 Recombinant hk2 polypeptide |
11/16/1995 | WO1995030757A2 Metalloproteases from fusarium and aspergillus having thermolysin-like activity |
11/16/1995 | WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
11/16/1995 | WO1995030753A1 CHIMERIC DELTA-ENDOTOXIN EXPRESSION IN $i(PSEUDOMONAS FLUORESCENS) |
11/16/1995 | WO1995030752A1 IMPROVED BACILLUS THURINGIENSIS δ-ENDOTOXIN |
11/16/1995 | WO1995030751A1 Lanthionine-containing antimicrobial compound |
11/16/1995 | WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
11/16/1995 | WO1995030740A1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof |
11/16/1995 | WO1995030739A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi |
11/16/1995 | WO1995030428A1 Human dnase |
11/16/1995 | WO1995019371A3 Expression of surface layer proteins |
11/16/1995 | WO1995018862A3 Tfda gene selectable markers in plants and the use thereof |
11/16/1995 | DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines |
11/16/1995 | DE19516018A1 Isolation of microorganisms able to produce peptide amidase by selection on two amide contg. media |
11/16/1995 | CA2189980A1 Thermostable alkaline phosphatase of thermus thermophilus |
11/16/1995 | CA2189774A1 Recombinant hk2 polypeptide |
11/16/1995 | CA2188795A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
11/16/1995 | CA2188453A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi |
11/16/1995 | CA2187534A1 Improved bacillus thuringiensis .delta.-endotoxin |
11/16/1995 | CA2186621A1 Lanthionine-containing antimicrobial compound |
11/16/1995 | CA2158977A1 Retroviral vectors having a reduced recombination rate |
11/15/1995 | EP0682115A1 Synthetic insecticidal crystal protein gene |
11/15/1995 | EP0682114A2 Expression of recombinant MPF-4, CPF-4, PF-4 and precursor compounds |
11/15/1995 | EP0682112A1 Method for archiving expression, or to improve the level of expression of a gene |
11/15/1995 | EP0682111A1 Chimeric or transgenic animal and process for screening pharmaceutical products |
11/15/1995 | EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides |
11/15/1995 | EP0682040A1 Humanized immunoglobulins and their production and use |
11/15/1995 | EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof |
11/15/1995 | EP0681610A1 Polypeptides having amidase activity, genetic tools and host microorganisms for obtaining same |
11/15/1995 | EP0681609A1 A process for the preparation of lipase |